Funded Tech Companies

Arixa Pharmaceuticals

Wondering who provided funding to Arixa Pharmaceuticals? Private investors joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
Arixa Pharmaceuticals
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
Undisclosed
Palo Alto, CA 94020
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Arixa Pharmaceuticals is developing oral antibiotics for resistant Gram-negative infections using our proprietary prodrug technology. We have successfully created a series of safe oral prodrugs of avibactam, a ß-lactamase inhibitor approved by FDA in 2015 as component of AVYCAZ.
Profile
Arixa Pharmaceuticals LinkedIn Company Profile
Social Media
Arixa Pharmaceuticals Company Twitter Account
Company News
Arixa Pharmaceuticals News
Facebook
Arixa Pharmaceuticals on Facebook
YouTube
Arixa Pharmaceuticals on YouTube
Last Transaction
5/2/2018

Financing History

Date
Type
Amount
Venture Equity
$8,000,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
John Freund
  John Freund LinkedIn Profile  John Freund Twitter Account  John Freund News  John Freund on Facebook
Chief Scientific Officer
Eric Gordon
  Eric Gordon LinkedIn Profile  Eric Gordon Twitter Account  Eric Gordon News  Eric Gordon on Facebook
Co-Founder
Joaquim Trias
  Joaquim Trias LinkedIn Profile  Joaquim Trias Twitter Account  Joaquim Trias News  Joaquim Trias on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Arive GmbH | Arize AI

     

    Share this article

     


    About Our Venture Capital Database

    Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary